Stocktwits on MSN19d
Wolfe Research Downgrades Robinhood Stock As Bull Case Has 'Largely Played Out' — Retail Loses No Cheer
Robinhood (HOOD) stock gained retail attention on Tuesday after Wolfe Research downgraded the stock to ‘Peer Perform’ from ‘Outperform’ and removed the previous price target of $51. According to The ...
Seeking Alpha27d
Oneok upgraded at Wolfe, as discounted valuation brings buying opportunity
Oneok (NYSE:OKE) +3.9% in Monday's trading as Wolfe Research upgrades shares to Outperform from Peer Perform with a $110 price target, saying the stock has fallen out of favor on near-term Bakken ...
Business Insider4d
SiTime strength tied to apparent content in iPhone 16e, says Wolfe Research
Wolfe keeps an Outperform rating and $275 price target on SiTime shares, which are up 14% to $174.46 in afternoon trading. Published first on TheFly – the ultimate source for real-time ...
Robinhood’s crypto-powered rally takes a breather as analysts say gains priced in
Robinhood Markets Inc. shares are heading for their worst week since August as they pull back from the crypto-fueled surge ...
Business Insider19d
Snowflake (SNOW) Rises after Wolfe Research Points to Improving Consumption Trends
Shares of Snowflake (SNOW) are up in today’s trading after Wolfe Research, led by five-star analyst Alex Zukin, upgraded the software company from Hold to Buy due to improving consumption trends ...
Nasdaq23d
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
SAN JOSE, Calif., Feb. 14, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...